RM

Robert Moses

Mr Moses has more than 40 years of experience in the pharmaceutical/ biotechnology industry. He was formerly Corporate Vice President of CSL Limited. Prior to joining CSL, Mr Moses was Managing Director of commercial law firm Freehills, Chairman and CEO of a NASDAQ listed medical service company, and Corporate Manager of New Business Development at ICI (now Orica). Mr Moses is also the former Non-Executive Chairman of TGR Biosciences Pty Ltd. Mr Moses also spent 17 years in various management roles at the multinational pharmaceutical company Eli Lilly.

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
PER
PER
15/12/219,090,201010,000,000N/A
ANP
ANP
15/12/219,090,201010,000,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
ANP
ANP
03/12/20
Issued
90,201$0.100$9,020Participation in share purchase plan
ANP
ANP
23/12/19
Issued
10,000,000$0.087$870,000Issue of options
ANP
ANP
20/12/19
Buy
100,000$0.088$8,800On-market trade
ANP
ANP
18/12/19
Buy
281,112$0.089$25,100On-market trade
ANP
ANP
16/12/19
Exercise
618,888$0.080$49,511Exercise of options